Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,276,762 papers from all fields of science
Search
Sign In
Create Free Account
aclidinium
Known as:
(3-Carbamoyl-3,3-diphenylpropyl)ethyldimethylammonium
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
3 relations
30 ACTUAT aclidinium bromide 0.4 MG/ACTUAT Dry Powder Inhaler [Tudorza]
aclidinium bromide
Narrower (1)
Tudorza
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Efficacy and cardiovascular safety profile of dual bronchodilation therapy in chronic obstructive pulmonary disease: A bidimensional comparative analysis across fixed-dose combinations.
P. Rogliani
,
M. Matera
,
+4 authors
L. Calzetta
Pulmonary Pharmacology & Therapeutics
2019
Corpus ID: 202573651
2018
2018
Comparison of the in vitro pharmacological profiles of long-acting muscarinic antagonists in human bronchus.
E. Naline
,
S. Grassin Delyle
,
+5 authors
P. Devillier
Pulmonary Pharmacology & Therapeutics
2018
Corpus ID: 4169115
Review
2018
Review
2018
Comparative efficacy of inhaled medications (ICS/LABA, LAMA, LAMA/LABA and SAMA) for COPD: a systematic review and network meta-analysis
M. Aziz
,
L. Tan
,
+5 authors
K. Ng
International Journal of COPD
2018
Corpus ID: 261246315
Purpose To assess the comparative efficacy of short-acting muscarinic antagonists (SAMAs), long-acting muscarinic antagonists…
Expand
Review
2017
Review
2017
Long-acting muscarinic antagonist (LAMA) plus long-acting beta-agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease (COPD).
N. Horita
,
A. Goto
,
+4 authors
T. Kaneko
Cochrane Database of Systematic Reviews
2017
Corpus ID: 205211007
BACKGROUND Three classes of inhaler medications are used to manage chronic obstructive pulmonary disease (COPD): long-acting beta…
Expand
Highly Cited
2017
Highly Cited
2017
ACTIVATE: the effect of aclidinium/formoterol on hyperinflation, exercise capacity, and physical activity in patients with COPD
H. Watz
,
T. Troosters
,
+7 authors
E. Garcia Gil
International Journal of COPD
2017
Corpus ID: 3419115
The Phase IV, 8-week, randomized, double-blind, placebo-controlled ACTIVATE study (NCT02424344) evaluated the effect of…
Expand
2016
2016
The efficacy of aclidinium/formoterol on lung function and symptoms in patients with COPD categorized by symptom status: a pooled analysis
M. Miravitlles
,
K. Chapman
,
Ferran Chuecos
,
A. Ribera
,
E. G. Gil
International Journal of COPD
2016
Corpus ID: 15361266
Background Patients with chronic obstructive pulmonary disease (COPD) experience respiratory symptoms, which impair quality of…
Expand
Review
2015
Review
2015
Diagnosis and Pharmacotherapy of Stable Chronic Obstructive Pulmonary Disease: The Finnish Guidelines
H. Kankaanranta
,
T. Harju
,
+6 authors
L. Lehtimäki
Basic & Clinical Pharmacology & Toxicology
2015
Corpus ID: 12991551
The Finnish Medical Society Duodecim initiated and managed the update of the Finnish national guideline for chronic obstructive…
Expand
Highly Cited
2013
Highly Cited
2013
Efficacy and Safety of Aclidinium Bromide Compared with Placebo and Tiotropium in Patients with Moderate-to-Severe Chronic Obstructive Pulmonary Disease: Results from a 6-week, Randomized, Controlled…
J. Beier
,
A. Kirsten
,
+4 authors
E. G. Gil
COPD
2013
Corpus ID: 18309392
Abstract Background: This randomized, double-blind, Phase IIIb study evaluated the 24-hour bronchodilatory efficacy of aclidinium…
Expand
Highly Cited
2010
Highly Cited
2010
Aclidinium inhibits cholinergic and tobacco smoke-induced MUC5AC in human airways
J. Cortijo
,
M. Mata
,
+4 authors
E. Morcillo
European Respiratory Journal
2010
Corpus ID: 10908649
Mucus hypersecretion and mucin MUC5AC overexpression are pathological features of chronic obstructive pulmonary disease (COPD…
Expand
Review
2008
Review
2008
Novel long‐acting bronchodilators for COPD and asthma
M. Cazzola
,
M. Matera
British Journal of Pharmacology
2008
Corpus ID: 5842570
An important step in simplifying asthma and chronic obstructive pulmonary disease (COPD) management and improving adherence with…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE